Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine

Journal of the Neurological Sciences

Volumn 138, Issue 1-2, 1996, Pages 60-65

  Limmroth, V ^a   May, A ^a   Auerbach, P ^a   Wosnitza, G ^a   Eppe, T ^a   Diener, H C ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Blood flow velocity; Doppler; Migraine; Sumatriptan; Vasoconstriction

Indexed keywords

PLACEBO; SUMATRIPTAN;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 0030002514     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(95)00344-2     Document Type: Article

References (24)

1. Buzzi, M.G., Moskowitz, M.A. (1990) The anti migraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br. J. Pharmacol. 99: 202-206.
2. Caekebeke, J.F.V., Ferrari, M.D., Zwetsloot, C.P., Jansen, J., Saxena, P.R. (1992) Anti migraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks. Neurology 42: 1522-1526.
3. Connor, H.E., Feniuk, W., Humphrey, P.P.A. (1989) Characterization of 5-HT receptors mediating contraction of canine and basilar artery by use of GR 43175, a selective 5-HT1-like receptor agonist. Br. J. Pharmacol. 96: 379-387.
4. Connor, H.E., Stubbs, C.M., Feniuk, W., Humphrey, P.P.A. (1992) Effect of sumatriptan, a selective 5-HT-like receptor agonist, on pial vessel diameter in anesthetized cats. J. Cereb. Blood Flow Metab. 12: 514-519.
5. Cutrer, F.M. Schoenfeld, D., Limmroth, V., Panahian, N., Moskowitz, M.A. (1995) Suppression by the sumatriptan analogue. CP-122.288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br. J. Pharmacol. 114: 987-992
6. Diener, H.C., Peters, C., Rudzio, M., Noe, A., Dichgans, J., Ehrmann, R., Tfelt-Hansen, P. (1991) Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraineurs. J. Neurol. 238: 245-250.
7. Ferrari, M.D., Haan, J., Blokland J.A.K., Arndt J.W., Minnee, P., Zwinderman A.H., Pauwels E.K.J., Saxena P.R. (1995) Cerebral blood flow during migraine attacks without aura and effect of sumatriptan. Arch. Neurol. 52: 135-139.
8. Friberg, L., Oleson, J., Iversen, H.K., Sperling, B. (1991) Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet II: 13-17.
9. Goadsby, P.J., Edvinsson, L. (1991) Sumatriptan reverses the changes in calcitonin gene related peptide seen in the headache phase of migraine. Cephalalgia 11, Sup. 11: 3-4.
10. Graham J.R., H.G. Wolf (1938) Mechanism of migraine headache and action of ergotamine tartrate. Arch. Neurol. Psychiatry 39: 737-763
11. Hamel, E., Fan, E., Linville, D., Ting, V., Villemure, J.G., Chia, L.S. (1993) Expression of mRNA for the serotonin 5-hydroxytryptamine 1dβ receptor subtype in human and bovine cerebral arteries. Mol. Pharmacol. 44: 242-246.
12. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 8. Suppl7: 1-96.
13. Humphrey, P.P.A., Apperly, E., Feniuk, W., Perren, M.J. (1990) A rational approach to identifying a fundamentally new drug for the treatment of migraine. In: Saxena et al. (eds). Cardiovascular pharmacology of 5-hydroxytryptamine, prospective therapeutic applications. Kluwer Academic Publishers. Dordrecht, 417-428.
14. Kobari, M., Fukuuchi, Y., Tomita, M., Tanahashi, N., Konno, S., Takeda, H. (1993) Effects of sumatriptan on the cerebral intraparenchymal microcirculation in the cat. Br. J. Pharmacol. 110: 1445-1448.
15. Moskowitz, M.A. (1992) Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci. 13: 307-311.
16. Nozaki, K., Moskowitz, M.A. and Boccalini, P. (1992). CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br. J. Pharmacol., 106: 409-415.
17. Pavy Le Traon, A., Cesari, J.B., Fabre, N., Morales, M.P., Geraud, G., Bes, A. (1989) Contribution of transcranial Doppler to the study of cerebral circulation in the migraineur. In: Clifford Rose (ed.) New advances in headache research. London: Smith-Gordon, 157-161.
18. Rebeck, G.W., Maynard, K.I., Hyman, B., Moskowitz, M.A. (1994) Selective 5-HT-1-D-alpha receptor gene expression in trigeminal ganglia: Implications for antimigraine drug development. Proc. Natl. Acad. Sci. 91: 3666-3669.
19. Schroth, G., Gerber, W.D., Langohr, H.D. (1983) Ultrasonic Doppler flow in migraine and Cluster headache. Headache 23, 284-288.
20. Scott, A.K., Grimes, S., Ng, K., Critchley, M., Breckenridge, A.M., Thomson, C. and Pilgrim, A.J. (1992) Sumatriptan and cerebral perfusion in healthy volunteers. Br. J. Pharmacol. 33: 401-404.
21. The Subcutaneous Sumatriptan International Study Group (1991) Treatment of migraine attacks with sumatriptan. N. Engl. J. Med. 325: 316-321.
22. Thie, A., Fuhlendorf, A., Spitzer, K., and Kunze, K. (1990) Transcranial Doppler evaluation of common and classical migraine. Part II. Ultrasonic features during attacks. Headache 30: 209-215.
23. Weiller, C., May, A., Limmroth, V., Jüptner, M., Kaube, H., v.Schayck, R., Coenen, H.H., Diener, H.C. (1995) Brain stem activation in spontaneous human migraine attacks. Nat. Med. 1: 1-4.
24. Zwetsloot, C.P., Caekebeke, C.V.J., Jansen, J.C., Odink, J., Ferrari, M.D. (1991) Blood flow velocity changes in migraine attacks: a transcranial Doppler study. Cephalalgia 11: 103-107.